AlphaCore Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
AlphaCore Capital's JNJ Position: Q2 2026 in Review
AlphaCore Capital increased its Johnson & Johnson (JNJ) stake by 52% in Q2 2026, buying an estimated $4.03M and bringing the position to 50,226 shares worth $12.8M. The position accounts for 0.23% of the portfolio, ranked #93.
AlphaCore Capital first reported a position in JNJ in Q1 2020 and has held it in 22 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- AlphaCore Capital held 50,226 shares of Johnson & Johnson worth $12.8M as of Q2 2026.
- AlphaCore Capital bought 17,289 Johnson & Johnson shares in Q2 2026, an estimated $4.03M.
- Johnson & Johnson made up 0.23% of AlphaCore Capital's portfolio in Q2 2026, its #93 holding.
- AlphaCore Capital first reported a position in Johnson & Johnson in Q1 2020 and has held it in 22 quarters since.
- 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.